COVID-19 infection in severe Alpha 1-antitrypsin deficiency: Looking for a rationale

The clinical manifestations of COVID-19 are heterogeneous: 46.4% of patients admitted into hospital reported to have at least one comorbidity. Comorbidities such as COPD, diabetes, hypertension and malignancy predispose patients with Covid-19 to adverse clinical outcomes. Alpha 1-antitrypsin deficie...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Respir Med
Autors principals: Ferrarotti, I., Ottaviani, S., Balderacchi, A.M., Barzon, V., De Silvestri, A., Piloni, D., Mariani, F., Corsico, A.G.
Format: Artigo
Idioma:Inglês
Publicat: Elsevier Ltd. 2021
Matèries:
Short Communication
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8086383/
https://ncbi.nlm.nih.gov/pubmed/33964815
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.rmed.2021.106440
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars